KTRA Kintara Therapeutics Inc
15,304
$0.1463
$0.005
(3.31%)
| Watchers | 15,304 |
| 52-Wk Low | $0.081 |
| 52-Wk High | $5.60 |
| Market Cap | $8.37M |
| Volume | 1.69M |
| 52-Wk High | $5.60 |
| 52-Wk Low | $0.081 |
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CVLY, CTLT, SCX, KTRAPR Newswire • 25 days ago
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CVLY, CTLT, SCX, KTRA SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CVLY, CTLT, SCX, KTRA PR Newswire NEW YORK, April 11, 2024 NEW...
Share to Feed
STOCKHOLDER INVESTIGATION: The M&A Class Action Firm Announces an Investigation of Kintara Biopharma, Inc. - KTRA STOCKHOLDER INVESTIGATION: The M&A Class Action Firm Announces an Investigation of...
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates MODN, SCX, KTRA SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates MODN, SCX, KTRA PR Newswire NEW YORK, April 8, 2024 NEW YORK, April...
NEW YORK, April 05, 2024 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or...
Kuehn Law Encourages KTRA, ABIO, SWAV, and NS Investors to Contact Law Firm Kuehn Law Encourages KTRA, ABIO, SWAV, and NS Investors to Contact Law Firm PR Newswire NEW YORK, April 5, 2024 NEW YORK...
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PIK, CHX, KTRA, ABIO SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PIK, CHX, KTRA, ABIO PR Newswire NEW YORK, April 4, 2024 NEW...
See the rest of the story here.
thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...
Kintara Therapeutics and TuHURA Biosciences Enter into Definitive Merger Agreement Kintara Therapeutics and TuHURA Biosciences Enter into Definitive Merger Agreement PR Newswire SAN DIEGO and TAMPA...
Shareholder Alert: Ademi LLP investigates whether Kintara Therapeutics, Inc. has obtained a Fair Price in its transaction with TuHURA Shareholder Alert: Ademi LLP investigates whether Kintara...
Gagnants
Le titre ARCA biopharma (NASDAQ:ABIO) a augment mercredi de 79,53% 3,07 dollars lors de la session ordinaire.
L'action Kintara Therapeutics (NASDAQ:KTRA) a augment de 72,31% 0,17...